Loading clinical trials...
Loading clinical trials...
Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness and Choroidal Vascularity Index in Emmetropes
Conditions
Interventions
Diffusion Optics Technology (DOT) Pattern Spectacle Lens
Control Spectacle Lens
Locations
1
Canada
Centre for Ocular Research and Education
Waterloo, Ontario, Canada
Start Date
January 18, 2023
Primary Completion Date
April 30, 2023
Completion Date
March 31, 2026
Last Updated
December 20, 2024
NCT07462897
NCT07505264
NCT07078799
NCT07329777
NCT07323251
NCT05770661
Lead Sponsor
SightGlass Vision, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions